Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oanh Dang

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Shock (Augusta, Ga.)|April 17, 2004
Inhibition of lipopolysaccharide-induced interferon regulatory factor 3 activation and protection from septic shock by hydroxystilbenesOanh Dang, Lorena Navarro, Michael David
Drug Safety|September 16, 2025
Characterizing the FDA Adverse Event Reporting System (FAERS) as a Network to Improve Pattern DiscoveryRaechel Davis, Oanh Dang, Suranjan De, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
Cutting edge: anthrax lethal toxin inhibits activation of IFN-regulatory factor 3 by lipopolysaccharideOanh Dang, Lorena Navarro, Keith Anderson, et al.
Expert Review of Anticancer Therapy|November 22, 2015
Pembrolizumab for the treatment of PD-L1 positive advanced or metastatic non-small cell lung cancerThu Oanh Dang, Adebayo Ogunniyi, Meagan S Barbee, et al.
The Annals of Pharmacotherapy|May 21, 2015
Current status and future directions of the immune checkpoint inhibitors ipilimumab, pembrolizumab, and nivolumab in oncologyMeagan S Barbee, Adebayo Ogunniyi, Troy Z Horvat, et al.
Journal of Medical Internet Research|June 6, 2024
Trust but Verify: Lessons Learned for the Application of AI to Case-Based Clinical Decision-Making From Postmarketing Drug Safety Assessment at the US Food and Drug AdministrationRobert Ball, Andrew H Talal, Oanh Dang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Cutting edge: apoptosis-regulating signal kinase 1 is required for reactive oxygen species-mediated activation of IFN regulatory factor 3 by lipopolysaccharideEdward Chiang, Oanh Dang, Keith Anderson, et al.
Experimental Biology and Medicine (Maywood, N.J.)|January 3, 2024
RxBERT: Enhancing drug labeling text mining and analysis with AI language modelingLeihong Wu, Magnus Gray, Oanh Dang, et al.
Journal of Biomedical Informatics|April 4, 2025
Deduplicating the FDA adverse event reporting system with a novel application of network-based groupingKory Kreimeyer, Jonathan Spiker, Oanh Dang, et al.
Biocontrol Science|March 19, 2019
Selection of Phages to Control Aeromonas hydrophila - An Infectious Agent in Striped CatfishHoang Hoang A, Xuan Tran T T, Nga LE P, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Shock (Augusta, Ga.)|April 17, 2004
Inhibition of lipopolysaccharide-induced interferon regulatory factor 3 activation and protection from septic shock by hydroxystilbenesOanh Dang, Lorena Navarro, Michael David
Drug Safety|September 16, 2025
Characterizing the FDA Adverse Event Reporting System (FAERS) as a Network to Improve Pattern DiscoveryRaechel Davis, Oanh Dang, Suranjan De, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
Cutting edge: anthrax lethal toxin inhibits activation of IFN-regulatory factor 3 by lipopolysaccharideOanh Dang, Lorena Navarro, Keith Anderson, et al.
Expert Review of Anticancer Therapy|November 22, 2015
Pembrolizumab for the treatment of PD-L1 positive advanced or metastatic non-small cell lung cancerThu Oanh Dang, Adebayo Ogunniyi, Meagan S Barbee, et al.
The Annals of Pharmacotherapy|May 21, 2015
Current status and future directions of the immune checkpoint inhibitors ipilimumab, pembrolizumab, and nivolumab in oncologyMeagan S Barbee, Adebayo Ogunniyi, Troy Z Horvat, et al.
Journal of Medical Internet Research|June 6, 2024
Trust but Verify: Lessons Learned for the Application of AI to Case-Based Clinical Decision-Making From Postmarketing Drug Safety Assessment at the US Food and Drug AdministrationRobert Ball, Andrew H Talal, Oanh Dang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Cutting edge: apoptosis-regulating signal kinase 1 is required for reactive oxygen species-mediated activation of IFN regulatory factor 3 by lipopolysaccharideEdward Chiang, Oanh Dang, Keith Anderson, et al.
Experimental Biology and Medicine (Maywood, N.J.)|January 3, 2024
RxBERT: Enhancing drug labeling text mining and analysis with AI language modelingLeihong Wu, Magnus Gray, Oanh Dang, et al.
Journal of Biomedical Informatics|April 4, 2025
Deduplicating the FDA adverse event reporting system with a novel application of network-based groupingKory Kreimeyer, Jonathan Spiker, Oanh Dang, et al.
Biocontrol Science|March 19, 2019
Selection of Phages to Control Aeromonas hydrophila - An Infectious Agent in Striped CatfishHoang Hoang A, Xuan Tran T T, Nga LE P, et al.
Pageof 3